Proton Pump
Proton pump is a protein complex that transport the H+ ion across the membranes of lysosomes and vacuoles to generate an electrical and chemical gradient that provide energy for ATP synthesis from ADP.
Products Related to Proton Pump(58)
- GC10599Esomeprazole SodiumCAS: 161796-78-7Purity: >99.50%
Esomeprazole Sodium is a potent and orally active proton pump inhibitor.
- GC13166OmeprazoleCAS: 73590-58-6Purity: >98.00%
Omeprazole is an inhibitor of gastric H + /K + ATPase (PPI) with an IC 50 value of 1.1μM for porcine ATPase. Omeprazole has competitive inhibitory effects on CYP2C19 activity with an inhibition constant (Ki) of 2 to 6μM.
- GC16516BCH (LAT1-IN-1)CAS: 20448-79-7Purity: >95.00%
BCH (LAT1-IN-1) is a selective and competitive inhibitor of the L-type amino acid transporter 1 (LAT1).
- GC16622DexlansoprazoleCAS: 138530-94-6Purity: >98%
Dexlansoprazole is the R enantiomer of Lansoprazole, Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid.
- GC17519Concanamycin ACAS: 80890-47-7Purity: >95.00%
Concanamycin A, a macrolide antibiotic, is a specific inhibitor of vacuolar-type ATPase (V-ATPase) with an IC 50 value of 10nM.
- GC17597Bafilomycin A1CAS: 88899-55-2Purity: >96.50%
Bafilomycin A1, a macrolide antibiotic, is a specific inhibitor of the vacuolar type H + -ATPase (V-ATPase) that inhibits the acidification of organelles containing V-ATPase, such as lysosomes and endosomes.
- GC25386Ethacrynate SodiumCAS: 6500-81-8Purity: >98%
Ethacrynate Sodium (ethacrynic acid sodium) is the sodium salt form of ethacrynic acid, which inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules.
- GC30130Soraprazan (BYK61359)CAS: 261944-46-1Purity: >99.50%
Soraprazan (BYK61359) (BYK61359) is a selective, reversible K-competitive inhibitor of the H,K-ATPase (Ki=6.4 nM), with an IC50 of 0.19 μM in gastric glands.
- GC31347Ilaprazole (IY-81149)CAS: 172152-36-2Purity: >98.00%
Ilaprazole (IY-81149) (IY-81149) is an orally active proton pump inhibitor.
- GC31426Bamaquimast (F 10126)CAS: 135779-82-7Purity: >98.00%
Bamaquimast (F 10126) (F 10126; L 0042) is a potent antiasthmatic drug.
- GC31466PicoprazoleCAS: 78090-11-6Purity: >98%
Picoprazole is a specific inhibitor of H+/K+-ATPase with IC50 of 3.1±0.4 μM.
- GC31969Pumaprazole (BY-841)CAS: 158364-59-1Purity: >99.50%
Pumaprazole (BY-841) is a reversible proton pump antagonist.
- GC32250Chebulinic acidCAS: 18942-26-2Purity: >98.00%
An ellagitannin with diverse biological activities
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10599 | Esomeprazole Sodium | 161796-78-7 | >99.50% | |
Esomeprazole Sodium is a potent and orally active proton pump inhibitor. | ||||
| GC12112 | Lansoprazole sodium | 226904-00-3 | >98% | |
PPI/cytochrome P450 inhibitor | ||||
| GC14313 | Esomeprazole Magnesium | 161973-10-0 | >98.00% | |
Proton pump inhibitor | ||||
| GC16453 | Zinc Pyrithione | 13463-41-7 | >98.00% | |
Proton pump inhibitor | ||||
| GC16570 | Lansoprazole | 103577-45-3 | >98.00% | |
H+,K+-ATPase inhibitor | ||||
| GC11151 | SCH 28080 | 76081-98-6 | >99.00% | |
H+,K+-ATPase inhibitor | ||||
| GC13022 | Esomeprazole Magnesium trihydrate | 217087-09-7 | >98% | |
An H + /K + -ATPase inhibitor | ||||
| GC13166 | Omeprazole | 73590-58-6 | >98.00% | |
Omeprazole is an inhibitor of gastric H + /K + ATPase (PPI) with an IC 50 value of 1.1μM for porcine ATPase. Omeprazole has competitive inhibitory effects on CYP2C19 activity with an inhibition constant (Ki) of 2 to 6μM. | ||||
| GC15334 | N2-Methyl-L-arginine | 2480-28-6 | >98% | |
Selective L-arginine uptake inhibitor | ||||
| GC15418 | TAK-438 | 1260141-27-2 | >98% | |
Blocker of potassium-competitive acid | ||||
| GC16516 | BCH (LAT1-IN-1) | 20448-79-7 | >95.00% | |
BCH (LAT1-IN-1) is a selective and competitive inhibitor of the L-type amino acid transporter 1 (LAT1). | ||||
| GC16622 | Dexlansoprazole | 138530-94-6 | >98% | |
Dexlansoprazole is the R enantiomer of Lansoprazole, Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. | ||||
| GC17519 | Concanamycin A | 80890-47-7 | >95.00% | |
Concanamycin A, a macrolide antibiotic, is a specific inhibitor of vacuolar-type ATPase (V-ATPase) with an IC 50 value of 10nM. | ||||
| GC17597 | Bafilomycin A1 | 88899-55-2 | >96.50% | |
Bafilomycin A1, a macrolide antibiotic, is a specific inhibitor of the vacuolar type H + -ATPase (V-ATPase) that inhibits the acidification of organelles containing V-ATPase, such as lysosomes and endosomes. | ||||
| GC25386 | Ethacrynate Sodium | 6500-81-8 | >98% | |
Ethacrynate Sodium (ethacrynic acid sodium) is the sodium salt form of ethacrynic acid, which inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. | ||||
| GC30130 | Soraprazan (BYK61359) | 261944-46-1 | >99.50% | |
Soraprazan (BYK61359) (BYK61359) is a selective, reversible K-competitive inhibitor of the H,K-ATPase (Ki=6.4 nM), with an IC50 of 0.19 μM in gastric glands. | ||||
| GC30418 | SKF96067 | 115607-61-9 | >98% | |
SKF96067 is a reversible inhibitor of the gastric H+/K+-ATPase. | ||||
| GC31347 | Ilaprazole (IY-81149) | 172152-36-2 | >98.00% | |
Ilaprazole (IY-81149) (IY-81149) is an orally active proton pump inhibitor. | ||||
| GC31426 | Bamaquimast (F 10126) | 135779-82-7 | >98.00% | |
Bamaquimast (F 10126) (F 10126; L 0042) is a potent antiasthmatic drug. | ||||
| GC31466 | Picoprazole | 78090-11-6 | >98% | |
Picoprazole is a specific inhibitor of H+/K+-ATPase with IC50 of 3.1±0.4 μM. | ||||
| GC31566 | Tegoprazan | 942195-55-3 | >98.50% | |
A proton pump inhibitor | ||||
| GC31969 | Pumaprazole (BY-841) | 158364-59-1 | >99.50% | |
Pumaprazole (BY-841) is a reversible proton pump antagonist. | ||||
| GC31987 | S3337 | 108499-48-5 | >98% | |
S3337 is an H+, K+-ATPase inhibitor. | ||||
| GC32250 | Chebulinic acid | 18942-26-2 | >98.00% | |
An ellagitannin with diverse biological activities | ||||